APA

Stein B. L., Williams D. M., O'Keefe C., Rogers O., Ingersoll R. G., Spivak J. L., Verma A., Maciejewski J. P., McDevitt M. A. & Moliterno A. R. (20120210). Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. : Haematologica.

Chicago

Stein Brady L, Williams Donna M, O'Keefe Christine, Rogers Ophelia, Ingersoll Roxann G, Spivak Jerry L, Verma Amit, Maciejewski Jarek P, McDevitt Michael A and Moliterno Alison R. 20120210. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. : Haematologica.

Harvard

Stein B. L., Williams D. M., O'Keefe C., Rogers O., Ingersoll R. G., Spivak J. L., Verma A., Maciejewski J. P., McDevitt M. A. and Moliterno A. R. (20120210). Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. : Haematologica.

MLA

Stein Brady L, Williams Donna M, O'Keefe Christine, Rogers Ophelia, Ingersoll Roxann G, Spivak Jerry L, Verma Amit, Maciejewski Jarek P, McDevitt Michael A and Moliterno Alison R. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. : Haematologica. 20120210.